Optional Non-CME Satellite Presentations
Thursday, May 14, 2026
11:50 AM – 12:50 PM EST
Hope ABC
Acthar Gel for the Treatment of Patients With Severe Inflammatory Disorders of the Anterior Segment of the Eye
Stephen Anesi, MD
Non-CME Satellite/Product Theatre presented by Keenova.
11:50 AM – 12:50 PM EST
Hope E
A New Therapeutic Paradigm for Dermatomyositis: Results from the Phase 3 VALOR Trial
Scott Jones (SVP, Physician Engagement, Priovant Therapeutics)
Non-CME Satellite/Product Theatre presented by Priovant Therapeutics.
Friday, May 15, 2026
7:45 – 8:30 AM EST
Hope E
Rinvoq Product Theater
Angela Kyei, MD, MPH, FAAD
Non-CME Satellite/Product Theatre presented by AbbVie.
12:10 – 1:10 PM EST
Hope ABC
A Biologic You Know Inhibiting IL-4 and IL-13 Signaling across Multiple Conditions Driven In Part by Type 2 Inflammation
Jason Hawkes, MD, MS, FAAD
View the invitation hereNon-CME Satellite/Product Theatre presented by Sanofi/Regeneron.
12:10 – 1:10 PM EST
Hope E
ICOTYDE - THE INNOVATIVE SCIENCE BEHIND TARGETED ORAL PEPTIDES in Moderate to Severe Plaque Psoriasis
Scott L. Gottlieb MD
Non-CME Satellite/Product Theatre presented by Johnson & Johnson.
Saturday, May 16, 2026
7:45 – 8:30 AM EST
Hope E
Explore Ebglyss
Amylynne Jaccarino Frankel, MD
Non-CME Satellite/Product Theatre presented by Eli Lilly & Co.
11:40 AM – 12:40 PM EST
Hope E
Choose RHAPSIDO: First-of-Its-Kind Oral BTKi Therapy for Chronic Spontaneous Urticaria
Walter Liszewski, MD
View the invitation hereNon-CME Satellite/Product Theatre presented by Novartis Pharmaceuticals.
These programs are developed and offered by industry supporters. They are not official programs of Cleveland Clinic.